-

Battelle Announces the Publication of its 2024 Consensus-Based Entity (CBE) Annual Report to Congress and the Secretary of Health and Human Services

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle, serving as a consensus-based entity (CBE), announced today the release of its 2024 Annual Report to Congress and the Secretary of Health and Human Services (HHS). The report highlights the significant progress and process improvements Battelle and its Partnership for Quality Measurement (PQM) have made in advancing health care quality measurement and improvement.

"HHS appreciates the efforts that the CBE has made to support our mutual commitment to promoting a resilient, high value, and safe health care system for all Americans,” wrote HHS Secretary Robert F. Kennedy, Jr., in his comments on the report.

The 2024 Annual Report details Battelle’s achievements in four key areas: Endorsement and Maintenance (E&M) of clinical quality measures, Pre-Rulemaking Measure Review (PRMR), Measure Set Review (MSR), and the Core Quality Measures Collaborative. In 2024 Battelle enhanced engagement and reduced committee burden by optimizing meeting schedules and voting structures for E&M committees. Public participation in the PRMR process was also robust, with 239 written and 51 verbal comments submitted by 234 professional organizations and 56 patients or patient representatives.

“HHS and the CBE both recognize the importance of clinical quality and cost/resource use measures in improving U.S. health care,” noted Kennedy. “Maintaining these measures through transparent, periodic, and consensus-based reviews is critical for ensuring health care quality performance can not only be measured but can also be improved upon.”

“This report reflects the collective commitment of Battelle and PQM members to advancing a more transparent, streamlined, and evidence-driven approach to health care quality,” said Nicole Brennan, MPH, DrPH, Executive Director of PQM. “We are proud to support HHS in ensuring that quality measures are not only scientifically sound but also meaningful to patients, providers, and policymakers alike.”

View the Secretarial Review of the 2024 Annual Report on the Federal Register.

About Battelle

Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers. Headquartered in Columbus, Ohio since its founding in 1929, Battelle serves the national security, health and life sciences, and energy and environmental industries. For more information, visit www.battelle.org.

About the Partnership for Quality Measurement

Battelle is a CMS-certified CBE that seeks to advance U.S. health care quality by bringing together interested parties to conduct statutorily required and enabled processes. Battelle formed the Partnership for Quality Measurement to convene members to perform these activities, which are organized into three tasks: E&M, PRMR, and MSR. For more information, visit p4qm.org.

Contacts

For more information, contact Katy Delaney at (614) 424-7208 or at delaneyk@battelle.org.

Industry:

Battelle

Release Versions
English

Contacts

For more information, contact Katy Delaney at (614) 424-7208 or at delaneyk@battelle.org.

More News From Battelle

Battelle Awarded Contract to Advance US Biological Threat Reduction

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle has been awarded the Defense Threat Reduction Agency’s (DTRA) Scientific and Technical Engagement Partnership (STEP) 2.0 contract, becoming the sole awardee for this major Biological Threat Reduction (BTR) effort. The award includes a $52.9 million base period, with a total potential value of $93.3 million over the full period of performance. The STEP 2.0 program operates under the Defense Threat Reduction Agency’s (DTRA) Global Threat Reduction (GTR) D...

Battelle Wins New Contract to Continue Environmental Research on Endocrine-disrupting Chemicals

COLUMBUS, Ohio--(BUSINESS WIRE)--The U.S. Environmental Protection Agency recently awarded Battelle one of three blanket purchase agreements to compete for research tasks to evaluate chemicals that may harm the endocrine system in animals and humans. Battelle and two other companies will bid on call orders with a total ceiling value of $44 million over five years to identify potential endocrine-disrupting chemicals and evaluate hazards, exposures, and risks to human health and the environment....

Decorated Senior Army Officer Tal Sullivan Joins Battelle

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle announced today that Tal Sullivan, a highly decorated retired U.S. Army Special Forces (Green Beret) Colonel with more than 30 years of military and leadership experience, has joined the organization as Senior Program Director for Human Performance and Optimization within its Health Research Division. Sullivan brings a distinguished career spanning military operations, program management, and strategic consulting. Most recently, he oversaw major strateg...
Back to Newsroom